AI assistant
Sending…
Nuvalent, Inc. — Director's Dealing 2023
Dec 20, 2023
30903_dirs_2023-12-20_a2d02a53-7790-4dd1-a8dc-51bee6b01289.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Nuvalent, Inc. (NUVL)
CIK: 0001861560
Period of Report: 2023-12-18
Reporting Person: Protopapas Anna (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-12-18 | Class A Common Stock | M | 5000 | $9.36 | Acquired | 5000 | Direct |
| 2023-12-18 | Class A Common Stock | S | 5000 | $75.67 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-12-18 | Stock Option (Right to Buy) | $9.36 | M | 5000 | Disposed | 2032-06-16 | Class A Common Stock (5000) | Direct |
Footnotes
F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.50 to $75.76, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price.
F2: This option is fully vested and exercisable.
More from Nuvalent, Inc.
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Regulatory Filings
2026
Apr 7
Director's Dealing
2026
Mar 30
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Annual Report
2026
Feb 26